» Articles » PMID: 37051621

Clinical Application of Three-dimensional T1-weighted BrainVIEW in Magnetic Resonance Imaging of Cerebral Venous Thrombosis: a Case Report and Literature Review

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2023 Apr 13
PMID 37051621
Authors
Affiliations
Soon will be listed here.
Abstract

To date, there is no clinical scoring system or laboratory indicator that can rule out cerebral venous thrombosis (CVT) or provide diagnostic proof for evaluating post-treatment thrombosis recanalization during follow-up. We therefore explored an imaging method for quantitative assessment of CVT and assessed thrombotic changes during follow-up. A patient presented with severe posterior occipital distension extending to the top of the forehead and an elevated plasma D-dimer (DD2) level. Computed tomography and pre-contrast-enhanced magnetic resonance imaging revealed only a small amount of cerebral hemorrhage. Three-dimensional (3D) T1-weighted (T1W) BrainVIEW pre-contrast-enhanced magnetic resonance scanning showed subacute thrombosis in the venous sinus, and the post-contrast-enhanced scan combined with volume rendering reconstruction showed cerebral thrombosis of the venous sinus and allowed for measurement of the thrombus volume. On days 30 and 60 of post-treatment follow-up, post-contrast-enhanced scans showed progressive reduction of the thrombus volume as well as recanalization and fibrotic flow voids in the chronic thrombosis. 3D T1W BrainVIEW was helpful to observe the size of the thrombi and the situation of venous sinus recanalization during the follow-up after clinical treatment of CVT. This technique can reflect the imaging manifestations of CVT throughout the whole process to guide clinical treatment decisions.

References
1.
Wakefield T, Strieter R, Wilke C, Kadell A, Wrobleski S, Burdick M . Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol. 1995; 15(2):258-68. DOI: 10.1161/01.atv.15.2.258. View

2.
Ferro J, Bousser M, Canhao P, Coutinho J, Crassard I, Dentali F . European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2019; 2(3):195-221. PMC: 6454824. DOI: 10.1177/2396987317719364. View

3.
Saposnik G, Barinagarrementeria F, Brown Jr R, Bushnell C, Cucchiara B, Cushman M . Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(4):1158-92. DOI: 10.1161/STR.0b013e31820a8364. View

4.
Saha P, Andia M, Modarai B, Blume U, Humphries J, Patel A . Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis. Circulation. 2013; 128(7):729-736. PMC: 3983557. DOI: 10.1161/CIRCULATIONAHA.113.001371. View

5.
Bapst B, Amegnizin J, Vignaud A, Kauv P, Maraval A, Kalsoum E . Post-contrast 3D T1-weighted TSE MR sequences (SPACE, CUBE, VISTA/BRAINVIEW, isoFSE, 3D MVOX): Technical aspects and clinical applications. J Neuroradiol. 2020; 47(5):358-368. DOI: 10.1016/j.neurad.2020.01.085. View